myelin

Biogen to Focus on RRMS Disease Management, Treatment at Upcoming Conference

Biogen plans toĀ present new clinical data at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 ā€“ 25, 2015, including numerous presentations focusing on multiple sclerosis. Ā In a company press release, Biogen statedĀ ā€œAt AAN, we will feature new scientific data, including research highlighting the…

Multiple Sclerosis Patients Could One Day Benefit From Brain Boost Study

A recent study suggests that in the futureĀ multiple sclerosis patients could benefit from treatments intendedĀ to boost their brain function. The study was published inĀ Nature NeuroscienceĀ and receivedĀ funding fromĀ The Wellcome Trust, the Lister Research Prize and the Biotechnology and Biological Sciences Research Council. According to researchers, patients…

Multiple Sclerosis Treatments Benefit From Discovery of New Inflammatory Molecule

A newly discovered molecule could play a pivotal role in inflammatory diseases, including multiple sclerosis, according to researchers at Trinity College Dublin and the University of Queensland Australia. The study was published in the journal Nature Medicine,Ā and describes aĀ molecule known as MCC950 that can suppress the ‘NLRP3 inflammasome’,…

Unraveling Myelin’s Mystery With Neutron Diffraction

Researchers have uncovered new information about myelin, a fatty substance that wraps around the axons of brain cells (neurons) allowing them to transmit information quickly from one cell to another. De-myelinating diseases in which the insulating wrap is damaged include multiple sclerosis, in which unpredictable loss of myelin causes…

Roche Turns to MS Research on Agreement with Versant Ventures

The Swiss pharmaceutical companyĀ RocheĀ recently announced a partnership agreement with California-based Inception Sciences and venture capital firm Versant Ventures. The three companies will work together to form a new company, Inception 5, which will be dedicated mostly to the development of therapies for multiple sclerosis. Inception 5’s research will focus…